Diffusion MRI

OTHER7 trials

Sponsors

Insel Gruppe AG, University Hospital Bern, University of Michigan Rogel Cancer Center, Jules Bordet Institute, University of British Columbia, Braintale

Conditions

Brain MRIColorectal CancerDiffuse Large B Cell LymphomaEpilepsyFractureKidney TransplantationMigraineProstate Cancer

Unknown Phase

Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy

Insel Gruppe AG, University Hospital BernKidney Transplantation, Urinary Calculi

Start: 2004-11-30End: 2024-12-31Updated: 2022-11-14

Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma

TerminatedNCT00645359

University of Michigan Rogel Cancer CenterDiffuse Large B Cell Lymphoma

Start: 2006-11-30End: 2014-04-30Updated: 2017-04-14

Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer

CompletedNCT01591590

Jules Bordet InstituteColorectal Cancer

Start: 2012-06-30End: 2021-09-25Updated: 2021-10-26

Diffusion MRI and Growth Plate Injuries: Pilot Study

University of British ColumbiaFracture

Start: 2014-11-30End: 2017-02-28Target: 10Updated: 2016-06-13

Early Assessment of Treatment Response Using Functional Diffusion Mapping

CompletedNCT02064283

University of Michigan Rogel Cancer CenterProstate Cancer

Start: 2007-05-31End: 2012-10-31Updated: 2014-12-09

Variability of Cerebral MRI Diffusion Parameters by Using a Patented Normalization Process vs no Use

BraintaleBrain MRI

Start: 2023-09-30End: 2024-05-31Target: 60Updated: 2023-08-01

High-field MR Imaging in Migraine, Visual Snow and Epilepsy

RecruitingNCT05524493

University of ZurichEpilepsy, Migraine, Visual Snow Syndrome

Start: 2025-03-01End: 2026-06-30Target: 200Updated: 2025-10-08

Related Papers

18F-FDG PET scan and liquid biopsy as tools to assess the pace of tumor progression and to predict overall survival (OS) in refractory colorectal cancer (rCRC): The CORIOLAN trial.

Journal of Clinical Oncology2020-05-20

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.

2014-05-302 citations